Home/Investors/U.S. Venture Partners

U.S. Venture Partners

Biotech Investor · 2 portfolio companies

Portfolio

Focus Areas

Top Stage

Commercial

Investment Focus

Company	Stage	Valuation	Focus
NeoChord	Commercial	—	Cardiovascular
VS3 Medical	First-in-Human / Early Feasibility	—	Neurovascular, Otology/Neurology